These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4869469)

  • 1. [On activation of fibrinolysis in vitro and in vivo by nicotinic acid, heparin and their mixtures].
    Goossens N
    Med Welt; 1967 Apr; 14():899-903. PubMed ID: 4869469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of epsilon-aminocaproic acid and of parotid inhibitor on the fibrinolysis activation due to nicotinic acid derivatives and to heparin-like substances.
    Gibelli A; Turazza G; Giarola P; De Nicola P
    Farmaco Sci; 1966 Apr; 21(4):301-9. PubMed ID: 4160699
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
    Kiseleva LN; Romanenko GK
    Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
    Sommer H
    Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multidirectional effect mechanism of heparin].
    Nilsson IM; Bielawiec M; Björkman S
    Pol Tyg Lek; 1966 Apr; 21(16):583-5. PubMed ID: 4223041
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic action of the tissue activator profibrinolysin and nicotinic acid].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1973; 19(4):371-4. PubMed ID: 4788286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of thrombophilic states by prolonged activation of fibrinolysis].
    De Nicola P
    Rev Atheroscler (Paris); 1967; 9(3):20-2. PubMed ID: 4174225
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and experimental studies on fibrinolysis activation].
    Bielawiec M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1967; 15():1-92. PubMed ID: 4953138
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits.
    De Nicola P; Gibelli A; Turazza G
    Thromb Diath Haemorrh; 1966 Jan; 15(1):231-7. PubMed ID: 5919803
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental research on prolonged fibrinolytic treatment. 2. Activation of fibrinolysis by prolonged administration of nicotinic acid derivatives].
    De Nicola P; Gibelli A; Frandoli G; Turazza G
    Hemostase; 1965 Dec; 5(4):343-51. PubMed ID: 5880346
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
    Tesi M
    Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the prolonged activation of fibrinolysis].
    Frandoli G; Gibelli A; Giarola PA; de Nicola P
    Arzneimittelforschung; 1967 Nov; 17(11):1397-400. PubMed ID: 5632155
    [No Abstract]   [Full Text] [Related]  

  • 17. [On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy].
    SAILER S; EBER O
    Klin Wochenschr; 1960 Jun; 38():548-51. PubMed ID: 14440816
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of Trasylol on blood coagulation and fibrinolysis after intravenous injection.
    Gormsen J
    Acta Chir Scand Suppl; 1967; 378():53-61. PubMed ID: 4966132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic principles of thrombolytic therapy].
    van de Loo J
    Internist (Berl); 1969 Jan; 10(1):16-21. PubMed ID: 4190309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.